| View |
|
BR-307
|
Hepatitis B Immunoglobulin (Human)
|
Hepabig
|
200 IU/mL
|
Solution For Injection
|
Prescription Drug (RX)
|
1 mL Glass Vial
|
Immunoglobulin
|
Green Cross Corporation
|
Korea
|
|
Vizcarra Pharmaceutical, Inc.
|
Vizcarra Pharmaceutical, Inc.
|
Renewal
|
07 April 2022
|
22 March 2027
|
| View |
|
BR-324
|
Diphtheria-Tetanus Toxoids and Pertussis (DTP)
|
Perdinus
|
30 IU (25 Lf) / 40 IU (5 Lf) / 4 IU per 0.5 mL
|
Suspension for Injection (IM) (Monodose)
|
Prescription Drug (RX)
|
0.5 mL One Point Cut (OPC) Glass Ampoule (Box of
50's)
|
Vaccine
|
Serum Institute of India Private Limited
|
India
|
|
Genpharm, Inc.
|
Genpharm, Inc.
|
Renewal
|
06 July 2025
|
28 December 2030
|
| View |
|
BR-325
|
Diphtheria-Tetanus Toxoid ( DT )
|
Ditevac
|
30 IU/ 40 IU per 0.5 mL
|
Suspension for Injection (IM) (Pediatric-Single Dose)
|
Prescription Drug (Rx)
|
Glass ampule x 0.5mL (Box of 50's)
|
VACCINE
|
Serum Institute of India Ltd.
|
India
|
|
Genpharm, Inc.
|
|
Renewal
|
10 August 2021
|
27 September 2026
|
| View |
|
BR-326
|
Tetanus Toxoid (Adsorbed)
|
T-Vac
|
5 Lf per 0.5mL
|
Suspension for Injection (IM)
|
Prescription Drug (Rx)
|
Ampoule x 0.5 mL (Box of 50's)
|
VACCINE
|
Serum Institute of India Ltd.
|
India
|
|
Genpharm, Inc.
|
Genpharm, Inc.
|
Automatic Renewal
|
10 August 2021
|
07 July 2026
|
| View |
|
BR-334
|
Hepabig
|
Hepatitis B Immunoglobulin (Human)
|
100 IU/0.5 mL
|
Solution For Injection
|
Prescription Drug (RX)
|
Vial
|
Immunoglobulin
|
Green Cross Corporation
|
Korea
|
|
Vizcarra Pharmaceutical, Inc.
|
Vizcarra Pharmaceutical, Inc.
|
Renewal
|
19 April 2022
|
06 April 2027
|
| View |
|
BR-349
|
Measles Vaccine (Live, Attenuated)
|
M-Vac
|
None
|
Lyophilized Powder for Injection (SC)
|
Prescription Drug (Rx)
|
Amber glass vial with grey bromobutyl rubber stopper
and orange flip-off cap, with Vaccine Vial Monitor (VVM) x 0.5 mL (as drug product) + Clear glass ampoule x 0.5 mL (Sterile Water for Injection as diluent) [Box of 1's, 10's, and 50's].
|
Vaccines
|
Serum Institute of India Pvt., Ltd.
|
India
|
|
Genpharm, Inc.
|
Genpharm, Inc.
|
Initial (Variation)
|
27 February 2024
|
27 February 2029
|
| View |
|
BR-359
|
Clostridium botulinum Type A Neurotoxin Complex
|
Botox
|
100 Units
|
Lyophilized Powder for Injection (IM)
|
Prescription Drug (RX)
|
Clear Glass Vial (Box of 1's)
|
Muscle Relaxant
|
Allergan Pharmaceuticals Ireland
|
Ireland
|
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
Regular Renewal
|
25 May 2025
|
26 September 2031
|
| View |
|
BR-409
|
Factor IX Complex
|
Profilnine SD
|
1000 IU/10mL
|
Iv
|
Prescription Drug (RX)
|
Type I glass vial + Type I pre-filled glass syringe x 5mL (Sterile Water for Injection as diluent) with 1 syringe-vial adapter, 1 infusion set and 2 alcohol swabs (Box of 1's). Single dose.
|
Plasma Fraction for Specific Use
|
Grifols Biologicals Inc.
|
U.S.A
|
|
GB Distributors, Inc.
|
GB Distributors, Inc.
|
Renewal
|
09 August 2019
|
05 October 2028
|
| View |
|
BR-411
|
Factor IX Complex
|
Profilnine SD
|
500 IU/5mL%
|
Iv
|
Prescription Drug (RX)
|
Type I glass vial + Type I pre-filled glass syringe x 5mL (Sterile Water for Injection as diluent) with 1 syringe-vial adapter, 1 infusion set and 2 alcohol swabs (Box of 1's). Single dose.
|
Plasma Fraction for Specific Use
|
Grifols Biologicals Inc.
|
U.S.A
|
|
GB Distributors, Inc.
|
GB Distributors, Inc.
|
Renewal
|
09 August 2019
|
16 October 2028
|
| View |
|
BR-415
|
Measles, Mumps, Rubella (MMR) Vaccine (Live, attenuated) [see formulation on reverse side]
|
Priorix
|
After reconstitution, each dose (0.5mL) contains:
Measles virus (Schwarz strain), live attenuated NLT 10 3.0 CCID 50
Mumps virus (RIT4385 strain), live attenuated NLT 10 3.7 CCID 50
Rubella virus (Wistar RA 27/3 strain), live attenuated NLT 10 3.0 CCID 50
|
Powder for Solution for Injection (SC)
|
Prescription Drug (Rx)
|
Each box contains: 3 mL Clear Glass Vial (Type I, Ph. Eur.) fitted with bromobutyl rubber stopper, aluminum overcap and flip-off cap; Type I glass syringes stoppered with a plunger stopper (diluent); 2 sterile needles (25G x 5/8") [Box of 1's and 100's]
|
-
|
GSK Biologicals SA
|
Belgium
|
|
GlaxoSmithKline Philippines, Inc.
|
|
-
|
30 March 2021
|
04 May 2026
|
| View |
|
BR-434
|
Measles, Mumps and Rubella Vaccine (Live, Attenuated)
|
Tresivac
|
Formulation: After reconstitution, one dose (0.5 mL) contains: Measles Virus-NLT 1,000 CCID 50 Mumps Virus-NLT 5,000 CCID 50 Rubella Virus -NLT 1,000 CCID 50
|
Freeze-dried Powder for Suspension for Injection (SC)
|
Prescription Drug (RX)
|
Type I amber glass vial + 0.5 mL Type I colourless glass ampoule (Sterile Water for Injection as diluent) (Box of 50s)
|
-
|
Serum Institute of India Private Limited
|
India
|
N/A
|
Genpharm, Inc.
|
Genpharm, Inc.
|
Initial (Variation)
|
04 October 2022
|
04 October 2027
|
| View |
|
BR-435
|
Tetanus Toxoid ( Adsorbed )
|
T-Vac
|
5Lf per 0.5mL
|
Suspension For Injection (I.M)
|
Prescription Drug (RX)
|
5 mL Vial (10 doses) / Box of 50 vials (Multidose)
|
-
|
Serum Institue of India Private Limited
|
India
|
N/A
|
Genpharm, Inc.
|
N/A
|
-
|
18 March 2022
|
07 July 2026
|
| View |
|
BR-442
|
Human Albumin
|
Human Albumin 20% Behring (Low Salt)
|
0.002
|
Solution for Intravenous Infusion
|
Prescription Drug (RX)
|
Infusion bottle of 50 mL or 100 mL (Box of 1's)
|
Plasma Fraction for Specific Use
|
CSL Behring GmbH
|
Germany
|
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
Renewal
|
06 August 2024
|
06 January 2030
|
| View |
|
BR-463
|
Human Albumin
|
Albutein 25% Solution
|
0.25
|
Solution for Injection for Infusion (IV)
|
Prescription Drug (RX)
|
50 mL or 100 mL USP Type II glass vial with gray overseal with chlorobutyl rubber stopper, and aluminum overseal with. willow green-color plastic flip-off seal (Box of 1's)
|
-
|
Grifols Biologicals LLC
|
U.S.A
|
N/A
|
GB Distributors, Inc.
|
N/A
|
Renewal
|
28 April 2023
|
25 May 2027
|
| View |
|
BR-470
|
Live Attenuated Measles Vaccine
|
Unbranded
|
Multidose
|
Freeze-Dried Powder For Injection (Multidose) (SC)
|
Prescription Drug (RX)
|
5 mL Glass Vial (10 Doses) + 5 mL Water for Injection Diluent (Box of 10's and 50's)
|
Vaccine
|
Serum Institute of India Private Limited
|
India
|
|
Genpharm, Inc.
|
Genpharm, Inc.
|
Renewal
|
06 July 2025
|
14 December 2030
|
| View |
|
BR-471
|
Tetanus Toxoid ( Adsorbed )
|
None
|
40IU/0.5mL
|
Suspension For Injection (IM) (Multidose)
|
Prescription Drug (RX)
|
Glass vial x 10mL(20doses) (Box of 25's)
|
-
|
Serum Institue of India Private Limited
|
India
|
N/A
|
Genpharm, Inc.
|
N/A
|
-
|
18 March 2022
|
30 August 2026
|
| View |
|
BR-488
|
Human Albumin
|
Zenalb-20
|
0.2
|
Solution For Injection (IV)
|
Prescription Drug (RX)
|
Type II clear glass vial x 50 mL (Box of 1's)
|
-
|
Bio Products Laboratory Limited
|
United
Kingdom
|
N/A
|
Britton Distributions, Inc.
|
Britton Distributions, Inc.
|
-
|
27 April 2022
|
03 March 2026
|
| View |
|
BR-500
|
Hepatitis B Vaccine (rdna)
|
Hepliv
|
20mcg/mL
|
Suspension for IM Injection
|
Prescription Drug (Rx)
|
10ml USP Type I Glass Vial (Box of 1's)- Multidose
|
Vaccine
|
Bharat Biotech International Ltd.
|
India
|
|
PHIL PHARMAWEALTH, INC.
|
PHIL PHARMAWEALTH, INC.
|
Automatic Renewal
|
19 October 2021
|
09 October 2026
|
| View |
|
BR-501
|
Hepatitis B Vaccine (rdna)
|
Hepliv
|
20mcg/ mL
|
Suspension for IM Injection
|
Prescription Drug (Rx)
|
1ml per USP Type I clear glass vial (Box of 10's)- Adult dose
|
Vaccine
|
Bharat Biotech International Ltd.
|
India
|
|
PHIL PHARMAWEALTH, INC.
|
PHIL PHARMAWEALTH, INC.
|
Automatic Renewal
|
13 October 2021
|
09 October 2026
|
| View |
|
BR-502
|
Hepatitis B Vaccine (rdna)
|
Hepliv
|
100mcg/ 0.5mL
|
Suspension for IM Injection
|
Prescription Drug (Rx)
|
0.5ml USP Type I clear glass vial (Box of 10's)- Pediatric dose
|
Vaccine
|
Bharat Biotech International Ltd.
|
India
|
|
PHIL PHARMAWEALTH, INC.
|
PHIL PHARMAWEALTH, INC.
|
Automatic Renewal
|
13 October 2021
|
09 October 2026
|